Hostname: page-component-cd9895bd7-gxg78 Total loading time: 0 Render date: 2024-12-23T06:24:15.697Z Has data issue: false hasContentIssue false
  • English
  • Français

A New Era for CNS Spectrums

Published online by Cambridge University Press:  07 November 2014

Andrew A. Nierenberg
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editor's Letter
Information
CNS Spectrums , Volume 14 , Issue 5 , May 2009 , pp. 232 - 233
Copyright
Copyright © Cambridge University Press 2009

References

REFERENCES

1.Insel, TR. Disruptive insights in psychiatry: transforming a clinical discipline. J Clin Invest. 2009;119:700–705.Google Scholar
2.Insel, TR. Translating scientific opportunity into public health impact: a strategic plan for research on mental illness. Arch Gen Psychiatry. 2009;66:128–133.Google Scholar
3.Gould, TD, Chen, G, Manji, HK. Mood stabilizer psychopharmacology. Clin Neurosci Res. 2002;2:193–212.Google Scholar
4.Marx, CE, Yuan, PX, Kilts, JD, Madison, RD, Shampine, LJ, Manji, HK. Neuroactive steroids, mood stabilizers, and neuroplasticity: alterations following lithium and changes in Bcl-2 knockout mice. Int J Neuropsychopharmacol. 2008;11:547–552.Google Scholar
5.Eriksson, PS, Perfilieva, E, Bjork-Eriksson, T, et, al, Neurogenesis in the adult human hippocampus. Nat Med. 1998;4:1313–1317.Google Scholar
6.Zhao, CM, Deng, W, Gage, FH. Mechanisms and functional implications of adult neurogenesis. Cell. 2008;132:645–660.Google Scholar
7.Sahay, A, Hen, R. Adult hippocampal neurogenesis in depression. Nat Neurosci. 2007;10:1110–1115.Google Scholar
8.Pezawas, L, Meyer-Lindenberg, A, Drabant, EM, et al.5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci. 2005;8:828–834.Google Scholar
9.Quiroz, JA, Gray, NA, Kato, T, Manji, HK. Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology. 2008;33:2551–2565.Google Scholar
10.Landis, S, Insel, TR. The “neuro” in neurogenetics. Science. 2008;322:821–821.Google Scholar
11.Lin, EG, Chen, PS. Pharmacogenomics with antidepressants in the STAR*D study. Pharmacogenomics. 2008;9:935–946.Google Scholar
12.Caspi, A, Sugden, K, Moffitt, TE, et al.Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–389.Google Scholar
13.Kendler, KS, Baker, JH. Genetic influences on measures of the environment: a systematic review. Psychol Med. 2007;37:615–626.Google Scholar
14.DeAngelis, CD. The influence of money on medical science. JAMA. 2006;296:996–998.Google Scholar
15.Angell, M. Drug Companies & Doctors: A Story of Corruption [New York Review of Books Web site]. January 15, 2009. Available at: http://www.nybooks.com/articles/22237. Accessed January 15, 2009.Google Scholar
16.Duvall, DG. Conflict of interest or ideological divide: the need for ongoing collaboration between physicians and industry. Curr Med Res Opin. 2006;22:1807–1812.Google Scholar
17.Stossel, TP. Regulating academic-industrial research relationships—solving problems or stifling progress? N Engl J Med. 2005;353:1060–1065.Google Scholar
18.Stossel, TP, Lee, K. Has the hunt for conflicts of interest gone too far? BMJ. 2008;336:476–477.Google Scholar
19.Nierenberg, AA. A counter proposal to manage financial conflicts of interest in academic psychiatry. World Psychiatry. 2007;6:34–36.Google Scholar